From The Hill
The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a…
Leave a Reply